Basic Therapeutic Approach for Patients with Plaque Psoriasis:Korean Expert Consensus Using the Modified Delphi Method
- Author:
Seong Jin JO
1
;
Yoo Sang BAEK
;
Tae-Gyun KIM
;
Ki-Heon JEONG
;
Jeong Eun KIM
;
Yu Sung CHOI
;
Byungsoo KIM
;
Eun-So LEE
;
Yong Beom CHOE
;
Author Information
- Publication Type:Original Article
- From:Annals of Dermatology 2023;35(3):173-182
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Currently, there is no consensus on the treatment of psoriasis in Korean patients.
Objective:This study aimed to establish a consensus on the basic therapeutic principles for Korean patients with plaque psoriasis.
Methods:Using the modified Delphi method, a steering committee proposed 53 statements for the first Delphi round, which covered five subjects: (1) the goal of treatment and evaluation of disease severity, (2) topical therapy, (3) phototherapy, (4) conventional systemic therapy, and (5) biologic therapy. The panel of dermatologists scored the level of agreement for each statement on a ten-point scale with scores ranging from 1 (strongly disagree) to 10 (strongly agree). After discussing the results of the first round, the committee reformulated 41 statements. Finally, consensus was defined as more than 70% of the second round scores being ≥7.
Results:The panel participants strongly agreed that the ideal treatment goals for Korean patients with plaque psoriasis should include complete skin clearance and high dermatological quality of life. A strong consensus was also reached on the use of topical agents for psoriasis of any severity, the consideration of phototherapy before biologics therapy, the conventional systemic agents for moderate-to-severe psoriasis, and the recommendation of biologic for retractable psoriasis to conventional systemic therapy and phototherapy.
Conclusion:This modified Delphi panel established an expert consensus on the therapeutic approach for Korean patients with plaque psoriasis. This consensus may improve the treatment outcomes for psoriasis in Korea.